Related Experiment Video
Updated: Jul 4, 2026
09:05
In Vitro Differentiation of Human Mesenchymal Stem Cells into Functional Cardiomyocyte-like Cells
Published on: August 9, 2017
[Differences between adipose-derived stem cells and mesenchymal stem cells in differentiation into cardiomyocytes]
Duan-Zhen Zhang1, Lu-Yue Gai, Hong-Wei Liu
1Department of Congenital Heart Disease, the General Hospital of Shenyang Military Region, Shenyang 110016, China.
Sheng Li Xue Bao : [Acta Physiologica Sinica]
|June 19, 2008
Summary
Adipose-derived stem cells (ASCs) show higher proliferation and differentiation rates into cardiomyocytes compared to bone marrow mesenchymal stem cells (MSCs). ASCs are more suitable for cellular cardiomyoplasty due to their advantages in tissue content and growth.
Area of Science:
- Regenerative Medicine
- Stem Cell Biology
- Cardiovascular Research
Background:
- Adipose-derived stem cells (ASCs) share similarities with bone marrow mesenchymal stem cells (MSCs) in key biological characteristics.
- Investigating the comparative efficacy of ASCs and MSCs in cardiomyocyte differentiation is crucial for regenerative therapies.
Purpose of the Study:
- To compare the in vitro culture and cardiomyocyte differentiation potential of ASCs and MSCs.
- To evaluate the influence of 5-azacytidine on the differentiation of ASCs and MSCs into cardiomyocytes.
- To assess the suitability of ASCs versus MSCs for cellular cardiomyoplasty.
Main Methods:
- ASCs isolated from rabbit adipose tissue and MSCs from rat bone marrow.
- Clonogenic assays to quantify stem cell content.
- In vitro culture and treatment with varying concentrations of 5-azacytidine.
- Morphological and phenotypic analysis post-differentiation.
Main Results:
- ASCs exhibited higher tissue content and proliferation rates than MSCs.
- ASCs differentiated into cardiomyocytes more efficiently and rapidly than MSCs following 5-azacytidine treatment.
- Age influenced MSC yield and differentiation potential, but not ASCs.
Conclusions:
- ASCs possess superior tissue content, growth kinetics, and differentiation capacity into cardiomyocytes compared to MSCs.
- ASCs demonstrate significant advantages over MSCs for applications in cellular cardiomyoplasty.
- These findings support the use of ASCs as a more promising stem cell source for cardiac repair.
Related Concept Videos
01:19Mesenchymal Stem Cells
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.